Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 13 | 2017 | 3000 | 1.400 |
Why?
|
| Motor Activity | 4 | 2014 | 327 | 0.850 |
Why?
|
| Cartoons as Topic | 1 | 2014 | 3 | 0.470 |
Why?
|
| Body Mass Index | 4 | 2013 | 771 | 0.460 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2013 | 45 | 0.450 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2013 | 27 | 0.450 |
Why?
|
| Health Education | 1 | 2014 | 105 | 0.440 |
Why?
|
| Reproductive Physiological Phenomena | 1 | 2012 | 4 | 0.420 |
Why?
|
| Health Promotion | 2 | 2014 | 163 | 0.420 |
Why?
|
| Walking | 2 | 2010 | 89 | 0.420 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2015 | 261 | 0.420 |
Why?
|
| Lactation | 1 | 2012 | 54 | 0.410 |
Why?
|
| Breast | 1 | 2013 | 292 | 0.390 |
Why?
|
| Breast Feeding | 1 | 2012 | 102 | 0.380 |
Why?
|
| Gasoline | 1 | 2011 | 4 | 0.380 |
Why?
|
| Feeding Behavior | 1 | 2014 | 327 | 0.380 |
Why?
|
| Environment Design | 1 | 2010 | 9 | 0.370 |
Why?
|
| Bicycling | 1 | 2010 | 12 | 0.370 |
Why?
|
| Diabetes Complications | 1 | 2012 | 170 | 0.370 |
Why?
|
| Running | 1 | 2010 | 25 | 0.360 |
Why?
|
| Neoplasm Metastasis | 2 | 2014 | 1108 | 0.340 |
Why?
|
| Mastectomy | 3 | 2017 | 245 | 0.340 |
Why?
|
| Residence Characteristics | 1 | 2010 | 200 | 0.320 |
Why?
|
| Risk Factors | 7 | 2014 | 5466 | 0.290 |
Why?
|
| Female | 22 | 2017 | 46011 | 0.270 |
Why?
|
| United States | 9 | 2017 | 6955 | 0.260 |
Why?
|
| Longitudinal Studies | 4 | 2013 | 1067 | 0.240 |
Why?
|
| Case-Control Studies | 3 | 2014 | 1855 | 0.240 |
Why?
|
| Logistic Models | 4 | 2017 | 1212 | 0.220 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 1176 | 0.220 |
Why?
|
| Young Adult | 7 | 2015 | 6288 | 0.220 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 2335 | 0.210 |
Why?
|
| Adult | 14 | 2015 | 26507 | 0.210 |
Why?
|
| Humans | 23 | 2017 | 89063 | 0.200 |
Why?
|
| Radiotherapy, Adjuvant | 3 | 2017 | 296 | 0.190 |
Why?
|
| Odds Ratio | 2 | 2013 | 684 | 0.190 |
Why?
|
| Body Weight | 3 | 2013 | 452 | 0.190 |
Why?
|
| Surveys and Questionnaires | 5 | 2014 | 2612 | 0.180 |
Why?
|
| Middle Aged | 10 | 2017 | 25863 | 0.160 |
Why?
|
| Adolescent | 8 | 2015 | 9237 | 0.150 |
Why?
|
| Receptors, Progesterone | 2 | 2017 | 174 | 0.140 |
Why?
|
| Aged | 7 | 2017 | 19077 | 0.140 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2017 | 156 | 0.140 |
Why?
|
| Nigeria | 2 | 2013 | 156 | 0.130 |
Why?
|
| Guideline Adherence | 1 | 2017 | 229 | 0.130 |
Why?
|
| Overweight | 2 | 2006 | 119 | 0.120 |
Why?
|
| Prospective Studies | 3 | 2013 | 4273 | 0.120 |
Why?
|
| Africa | 1 | 2014 | 101 | 0.120 |
Why?
|
| Carcinoma, Lobular | 1 | 2015 | 81 | 0.120 |
Why?
|
| Literature | 1 | 2014 | 2 | 0.120 |
Why?
|
| New York City | 1 | 2014 | 61 | 0.120 |
Why?
|
| Lymph Node Excision | 1 | 2015 | 220 | 0.120 |
Why?
|
| Life Style | 1 | 2015 | 172 | 0.120 |
Why?
|
| Quality of Health Care | 1 | 2017 | 385 | 0.110 |
Why?
|
| Vegetables | 1 | 2014 | 47 | 0.110 |
Why?
|
| Occupational Exposure | 1 | 2015 | 87 | 0.110 |
Why?
|
| Fruit | 1 | 2014 | 76 | 0.110 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2015 | 158 | 0.110 |
Why?
|
| Premenopause | 1 | 2013 | 57 | 0.110 |
Why?
|
| Parity | 1 | 2013 | 96 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2015 | 184 | 0.110 |
Why?
|
| Postmenopause | 1 | 2013 | 102 | 0.110 |
Why?
|
| Indians, North American | 1 | 2013 | 47 | 0.110 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 147 | 0.110 |
Why?
|
| Age Distribution | 1 | 2013 | 200 | 0.100 |
Why?
|
| Tanzania | 1 | 2012 | 47 | 0.100 |
Why?
|
| Hereditary Breast and Ovarian Cancer Syndrome | 1 | 2012 | 10 | 0.100 |
Why?
|
| SEER Program | 1 | 2013 | 197 | 0.100 |
Why?
|
| Registries | 2 | 2014 | 778 | 0.100 |
Why?
|
| Postpartum Period | 1 | 2013 | 144 | 0.100 |
Why?
|
| Students | 1 | 2014 | 169 | 0.100 |
Why?
|
| Carcinoma | 1 | 2015 | 443 | 0.100 |
Why?
|
| Alcohol Drinking | 1 | 2014 | 273 | 0.100 |
Why?
|
| Neoplasms, Second Primary | 1 | 2014 | 260 | 0.100 |
Why?
|
| BRCA2 Protein | 1 | 2012 | 161 | 0.100 |
Why?
|
| Lymph Nodes | 1 | 2015 | 548 | 0.090 |
Why?
|
| Obesity | 2 | 2008 | 966 | 0.090 |
Why?
|
| BRCA1 Protein | 1 | 2012 | 204 | 0.090 |
Why?
|
| Social Class | 1 | 2011 | 135 | 0.090 |
Why?
|
| Mammography | 1 | 2013 | 471 | 0.090 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 6777 | 0.090 |
Why?
|
| Survivors | 1 | 2011 | 233 | 0.090 |
Why?
|
| Male | 9 | 2014 | 42251 | 0.090 |
Why?
|
| Germ-Line Mutation | 1 | 2012 | 344 | 0.080 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 415 | 0.080 |
Why?
|
| Urban Population | 1 | 2010 | 224 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 3657 | 0.080 |
Why?
|
| Energy Intake | 1 | 2008 | 97 | 0.080 |
Why?
|
| Incidence | 1 | 2013 | 1592 | 0.080 |
Why?
|
| Weight Gain | 1 | 2008 | 119 | 0.080 |
Why?
|
| Prognosis | 2 | 2015 | 3773 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 1363 | 0.070 |
Why?
|
| Child | 4 | 2014 | 7149 | 0.070 |
Why?
|
| Crohn Disease | 1 | 2014 | 758 | 0.070 |
Why?
|
| Colitis, Ulcerative | 1 | 2014 | 736 | 0.070 |
Why?
|
| Age Factors | 4 | 2017 | 1867 | 0.070 |
Why?
|
| Neoplasm Staging | 3 | 2017 | 2001 | 0.070 |
Why?
|
| Pregnancy | 1 | 2013 | 3009 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2013 | 2290 | 0.070 |
Why?
|
| Body Composition | 1 | 2005 | 71 | 0.060 |
Why?
|
| Child Behavior | 1 | 2005 | 47 | 0.060 |
Why?
|
| Cross-Sectional Studies | 4 | 2014 | 1706 | 0.060 |
Why?
|
| Adolescent Behavior | 1 | 2005 | 109 | 0.060 |
Why?
|
| Health Behavior | 1 | 2005 | 184 | 0.060 |
Why?
|
| Exercise | 1 | 2005 | 322 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2017 | 2863 | 0.040 |
Why?
|
| Mastectomy, Segmental | 1 | 2017 | 101 | 0.030 |
Why?
|
| Neoplasms | 1 | 2011 | 3035 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2017 | 485 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2017 | 393 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 848 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2014 | 21 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 988 | 0.030 |
Why?
|
| Sacroiliitis | 1 | 2014 | 3 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 421 | 0.030 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2014 | 25 | 0.030 |
Why?
|
| Ileal Diseases | 1 | 2014 | 26 | 0.030 |
Why?
|
| Arthralgia | 1 | 2014 | 39 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2015 | 502 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 106 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 850 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 576 | 0.030 |
Why?
|
| Barbados | 1 | 2012 | 7 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2017 | 9003 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2014 | 369 | 0.030 |
Why?
|
| Guam | 1 | 2011 | 1 | 0.030 |
Why?
|
| West Indies | 1 | 2011 | 4 | 0.030 |
Why?
|
| Sex Factors | 2 | 2005 | 1063 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 1710 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 1889 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 529 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 294 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2011 | 216 | 0.020 |
Why?
|
| Genital Neoplasms, Female | 1 | 2011 | 108 | 0.020 |
Why?
|
| Biopsy | 1 | 2014 | 1182 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 1043 | 0.020 |
Why?
|
| Self Report | 1 | 2011 | 295 | 0.020 |
Why?
|
| Chicago | 1 | 2014 | 1423 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 582 | 0.020 |
Why?
|
| Leisure Activities | 1 | 2008 | 8 | 0.020 |
Why?
|
| Marital Status | 1 | 2008 | 42 | 0.020 |
Why?
|
| Base Sequence | 1 | 2012 | 2327 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 1837 | 0.020 |
Why?
|
| Educational Status | 1 | 2008 | 194 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 3027 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 2439 | 0.020 |
Why?
|
| Genotype | 1 | 2012 | 1848 | 0.020 |
Why?
|
| Russia | 1 | 2006 | 26 | 0.020 |
Why?
|
| Brazil | 1 | 2006 | 71 | 0.020 |
Why?
|
| Australia | 1 | 2006 | 101 | 0.020 |
Why?
|
| United Kingdom | 1 | 2006 | 164 | 0.020 |
Why?
|
| China | 1 | 2006 | 233 | 0.020 |
Why?
|
| Health Surveys | 1 | 2006 | 240 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 306 | 0.020 |
Why?
|
| Rural Population | 1 | 2005 | 143 | 0.020 |
Why?
|
| Smoking | 1 | 2008 | 620 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 981 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2005 | 266 | 0.010 |
Why?
|
| Prevalence | 1 | 2006 | 1240 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 1768 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 2752 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 5320 | 0.010 |
Why?
|